A 60-year-old obese male patient was admitted to the coronary care unit complaining of typical angina (CCS4). The patient's history included chronic renal failure and subsequent kidney transplantation, long-term hypertension, and coronary artery disease. In 1990, he underwent surgical revascularization, where 3 venous grafts to left artery descending (LAD), circumflex artery (Cx), and right coronary artery were implanted. After 13 years the patient was referred for a complex percutaneous coronary intervention (PCI) including bare-metal stent (BMS) implantation to Cx, marginal branch and saphenous graft to LAD. At presentation, standard electrocardiogram revealed no new abnormalities with troponin T of 0
A 60-year-old obese male patient was admitted to the coronary care unit complaining of typical angina (CCS4). The patient's history included chronic renal failure and subsequent kidney transplantation, long-term hypertension, and coronary artery disease. In 1990, he underwent surgical revascularization, where 3 venous grafts to left artery descending (LAD), circumflex artery (Cx), and right coronary artery were implanted. After 13 years the patient was referred for a complex percutaneous coronary intervention (PCI) including bare-metal stent (BMS) implantation to Cx, marginal branch and saphenous graft to LAD. At presentation, standard electrocardiogram revealed no new abnormalities with troponin T of 0.1 ng/mL. Echocardiography showed a pathological extracardiac structure adjacent to the left ventricle anterior wall (Fig. 1A, B) . The subsequent angiography revealed a significant multivessel disease comprising a severe stenosis of the distal portion of Cx and a giant (80 × 50 mm) saphenous venousgraft aneurysm (SVGA) to LAD with intramural thrombus formations, in-stent restenosis, and preserved Thrombolysis in Myocardial Infarction grade 3 flow (Fig. 1C) . Three-dimentional computed tomography angiography (CTA) (Fig. 1D ) and exercise-induced myocardial ischemia with Tc-99m sestamibi single-photon emission computed tomography were performed for the purpose of precise structural evaluation of the venous graft and myocardial perfusion in the area of LAD, respectively. Considering the high risk of reoperation and no substantial anterior wall ischemia the patient was offered a percutaneous treatment of Cx. The PCI and subsequent BMS implantation was performed with an excellent final result. After the procedure, the patient remained asymptomatic and discharged home in a good clinical condition. The long-term follow-up was uneventful.
Aneurysmal dilatation of saphenous vein graft remains an extremely rare surgical complication after coronary artery by-pass graft procedure. Although no screening guideline related to the aortocoronary SVGA exists, the incidence has been ascertained to be around 0.07% in a single center experience. In several cases, the symptoms of myocardial ischemia were documented owing to a distal embolization, fistula drainage, mass effect in the native vessel, or even rupture resulting in hemodynamic compromise [1] [2] [3] [4] . Nevertheless, SVGAs, by their asymptomatic course, seem to be underdiagnosed and are mainly identified accidentally on imaging [5] . Previously, patients with SVGAs were referred for surgical strategy. With refinement of percutaneous techniques, treatment strategies in patients with SVGAs are diverse, comprising, implantation of Amplatzer device, stentgrafts, and arterial coils [6] . Recently, several novel techniques have been described, including the transluminal reconstruction, to seal the aneurysm and restore distal flow [7] [8] [9] [10] . Since there is no consensus on the optimal approach in patients with SVGA, Ramirez et al. [6] proposed management algorithm identifying individuals best suited for percutaneous or surgical treatment strategy [3] . There is no doubt that all these patients, if possible, should be assessed by the heart-team. The first step in deciding on management options for SVGAs is to assess for the presence of mechanical complications and/or other surgical indication. In cases with patent SVGAs and suitable anatomy, percutaneous management with a covered stent should be pursued [3] . Multimodality imaging is often required to establish the size of the SVGA and the area supplied by affected graft [11] . Last but not least, the assessment of clinical symptoms and myocardial viability plays a key role in this diverse setting.
What sets our this case apart from most other ones is the fact of recording an unusual size of aneurysm, which sometimes can be hardly distinguished from pseudoaneurysm, even on the CTA scans. Any surgical intervention on a degenerated bypass was exposed to unreasonable risk of a massive intraoperative bleeding. Thus, since the imaging examination did not reveal any essential ischemia of the anterior wall, to avoid reoperation in this high-risk patient, conservative management was sought, following heart team discussion achieving a satisfactory long-tem clinical result. 
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